Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20120707010203N10Phase 2Completed
Phase 2, randomised, triple-blind trial in pityriasis versicolor comparing Fluconazole nanoemulgel with Clotrimazole cream (2 arms). Primary endpoint: Skin lesion area. Started Apr 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20120707010203N10.